KAO JOHN E 4

What Happened John E. Kao, CEO of Alignment Healthcare (ALHC), sold a total of 298,000 shares in open-market transactions on May 11, 2026, reporting proceeds of about $5.03 million. The sales break down as 280,893 shares at a weighted-average price of $16.85 (proceeds $4,732,879) and 17,107 shares at a weighted-average price of $17.54 (proceeds $299,971). These transactions are reported as sales (S), not purchases.

Key Details

• Transaction date: May 11, 2026; Form 4 filed May 13, 2026 (timely under the two-business-day rule).
• Prices: weighted-average prices reported as $16.85 and $17.54; per-share ranges noted in footnotes:
  • First block sold at per-share prices between $16.22 and $17.16 (weighted avg $16.85).
  • Second block sold at per-share prices between $17.22 and $17.70 (weighted avg $17.54).
• Total shares sold: 298,000; total reported proceeds: $5,032,850.
• Footnotes: transactions were made pursuant to a Rule 10b5-1 trading plan adopted 11/21/2025 (F1). Some reported securities are associated with the JEK Trust (Mr. Kao is trustee) (F3). The filer offers to provide full per-price breakdown on request (F2, F4).
• Shares owned after the transaction: not specified in the excerpt of this filing.

Context Sales under a pre-arranged Rule 10b5-1 plan are common for executives and are generally treated as routine liquidity events rather than direct signals of company outlook. This filing documents open-market sales by the CEO; it does not disclose motivation. Retail investors who track insider buying/selling can view these sales as part of broader insider activity, but should consider other signals (multiple insider buys, company fundamentals, and timing) before drawing conclusions.